Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Torben Noerup Nielsen who wrote (29945)	1/7/2000 3:13:00 PM
From: Webhead	Read Replies (1) \| Respond to of 32384

Out of a strong sense of respect for a properly conducted scientific trial I hearby volunteer for the double blind PIII. Actually, maybe the dose escalation trial would be the better choice... Ed "By the way, if you haven't already tried it, try get a hold of a young bottle of Caol Ila. About 10 years or so. It's delicious and in some ways superior to Laphroaig. Although it is such a close call that I expect to need several more years of carefully conducted trials to render a final verdict..... :-) Thanks, Torben"